Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
-
Shares outstanding
-
264,351,875
-
Total 13F shares
-
23,173,297
-
Share change
-
+10,243,301
-
Total reported value
-
$1,123,137,433
-
Price per share
-
$48.47
-
Number of holders
-
79
-
Value change
-
+$496,891,577
-
Number of buys
-
53
-
Number of sells
-
24
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q1 2021
As of 31 Mar 2021 NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) had 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,173,297 shares of stock of the company.
Largest 10 holders included HILLHOUSE CAPITAL ADVISORS, LTD., Cederberg Capital Ltd, Ward Ferry Management (BVI) Ltd, Avidity Partners Management LP, ADAGE CAPITAL PARTNERS GP, L.L.C., Artisan Partners Limited Partnership, Artal Group S.A., MANUFACTURERS LIFE INSURANCE COMPANY, THE, PRICE T ROWE ASSOCIATES INC /MD/, and Octagon Capital Advisors LP.
This table shows 78 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.